Skip To Content
Expanded Access to Investigational Drugs and Devices is a Course

Expanded Access to Investigational Drugs and Devices



Full course description

THIS LISTING IS THE TBA SESSION OF THIS CLASS. To be notified when a session of this class is scheduled, or if you cannot attend the already scheduled course, please enroll in this class.

The Food and Drug Administration (FDA) Expanded Access Program allows for investigational drugs and devices (i.e., non-FDA approved) to be used for treatment outside of a clinical trial. While such treatment use is not considered a clinical investigation, FDA submission and Institutional Review Board (IRB) review are necessary. This presentation will discuss the criteria for evaluating and securing FDA Expanded Access Program approval for investigational drugs and devices. The required FDA protocols and IRB procedural steps that must be followed for individual patients, intermediate-size patient populations and large patient populations will be described.

Sign up for this course today!